Today we are partnering with clinicians and hospitals around the world to add clinical value in the detection and treatment of cancer.
Science that keeps evolving As our collective understanding of how to detect, stage and treat cancer continues to evolve – and so do our technology solutions.
Our commitment is to provide technologies and support that enable:
accurate registration of anatomical and biological data
biological assessment of disease characteristics
data integration into your care cycle workflow for effective treatment decisions
And means that the physician can:
detect disease earlier, when there are often more treatment options
Useful content
We have created this oncology clinical segment to inform you about our technologies and the results achieved through this approach.
Our story is told with the assistance of…
Groups and institutions who have collaborated with us to develop groundbreaking oncology innovations
Customers with whom we have partnered to ensure a cohesive and efficient end-to-end solution
Technologies that continue to converge and provide new cross-functional insights
Physicians who’ve discovered that this convergence of technologies supports open collaboration between specialists
Your voice We believe products and applications become most valuable when they are shaped and refined by the real needs of customers like you. You’ll find that in evidence here.
Our obligation is to develop user-friendly advanced technologies that help drive the positive evolution of cancer care.
It’s apparent - our futures are inexorably entwined – customer and company.
hard as they can to get the patient’s treatment started as soon as possible. Philips MBS helps me give them what they want. In fact, this new tool set has helped us shave four and a half minutes off our brain contouring time. We’re saving nearly seven minutes on femur contours and almost five minutes on kidney contours. Our goal is to reduce overall contouring time for many, if not all, of our patients. MBS is helping us to do just that.